A Phase 3 Study of NTLA-2001 in ATTRv-PN

Clinical trial NCT06672237 · RECRUITING

Trial details

NCT number: NCT06672237
Sponsor: Intellia Therapeutics
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Neuromuscular Disease Neuromuscular Diseases (NMD)Neurodegenerative Disease Neurodegenerative Disease, Hereditary Neurodegenerative Diseases Neuromuscular Diseases Nerve Disorders Nervous System Disease Nervous System Diseases Genetic Disease, Inborn Amyloidosis, Familial Amyloidosis, Hereditary

Start date: 2024-11-22
Primary completion: 2027-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.